However, people are now experiencing an array of negative side effects from taking the drug, including nausea, vomiting, intestinal blockages, bowel injuries/stomach paralysis (gastroparesis), and inability to push waste out of the body (ileus)
The mean dose of insulin glargine at baseline was 34, 32, 35, and 33 units/day for patients receiving MOUNJARO 5 mg, 10 mg, 15 mg, and placebo, respectively
Both patterns are normal as your body finds its new equilibrium
Rushing dose escalation increases side effects without proportionally increasing weight loss, and severe side effects can force dose reductions that effectively waste medication
The flat-by-dose tirzepatide pricing is the legitimate hook here